Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Kisspeptin-10

KP-10, Metastin (45-54), Kisspeptin-10 (human), KiSS-1

Quick Stats
Studies 877
Trials 47
2022 pubmed 3 citations

Effects of kisspeptin-10 on the reproductive performance of sows in a fixed-time artificial insemination programme.

Qin. Y S YS; Bai. J H JH; Zhang. S L SL; Dai. J G JG; Xu. X L XL; Feng. T T; Song. Y Q YQ; Xiao. L L LL; Liu. Y Y

Key Findings

  • 0.5 mg kisspeptin‑10 given 96 h after weaning lengthened estrus duration compared to GnRH
  • LH peaks were modestly higher with kisspeptin‑10 than with GnRH
  • Pregnancy rates and litter size were unchanged across treatments

Practical Outcomes

  • The results show kisspeptin‑10 can replace GnRH for timing ovulation in sows, but there’s no clear benefit for human health or performance, so it isn’t a useful protocol for biohackers.

Summary

In a study on 198 weaned sows, giving a low dose (0.5 mg) of the peptide kisspeptin‑10 96 hours after weaning didn’t change whether the animals went into heat or got pregnant, but it made the heat period a bit longer and caused a slightly bigger hormone (LH) spike compared to the standard GnRH injection.

Abstract

Kisspeptin (KP) is a major positive regulator of the hypothalamo-pituitary-gonadal axis and affects female reproductive cyclicity in mammals. It offers an attractive alternative strategy to control reproduction in fixed-time artificial insemination (FTAI) protocols. We aimed to evaluate the effects of different doses of kisspeptin-10 (KP-10) on sow reproductive performance in FTAI protocols. One hundred ninety-eight weaned sows were divided into three groups at random. A FTAI-GnRH group of sows (n&#x202f;=&#x202f;98) received 100&#x202f;&#xb5;g (2&#x202f;mL) gonadotropin-releasing hormone (GnRH; gonadorelin) by intramuscular injection at 96&#x202f;h after weaning (t&#x202f;=&#x202f;0&#x202f;h); FTAI-KPL (KPL: low-dose KP-10, n&#x202f;=&#x202f;50), and FTAI-KPH groups of sows (KPH: high-dose KP-10, n&#x202f;=&#x202f;50) received 0.5 or 1&#x202f;mg KP-10 (2&#x202f;mL) respectively at 96&#x202f;h after weaning. Sows were checked twice daily for oestrus. Ultrasonographic evaluations were performed to determine the follicular diameter and time of ovulation; blood samples were collected immediately before injection (t<sub>0</sub>&#x202f;=&#x202f;0&#x202f;min) and at 15, 30, 45, 60, 75, 90&#x202f;min, 24 and 48&#x202f;h postinjection. Sows were inseminated at 112 and 132&#x202f;h after weaning. The oestrus rates (96 vs 92%; 96 vs 88%) and weaning-to-oestrus intervals (98.9 vs 98.6&#x202f;h; 98.9 vs 97.1&#x202f;h) were not affected by treatment, but oestrus in the FTAI-KPL group was significantly longer than in the FTAI-GnRH group (38.7 vs 30.0&#x202f;h; P&#x202f;&lt;&#x202f;0.05). The peak LH concentrations were 1.29 times greater than at t<sub>0</sub>&#x202f;=&#x202f;0 in the FTAI-GnRH group, and 1.45 and 1.44 times greater than at t<sub>0</sub>&#x202f;=&#x202f;0 in the FTAI-KPL and FTAI-KPH groups, respectively. Follicular diameters and pregnancy rates (86 vs 88%, 86 vs 80%, respectively) did not differ between the treatments. Moreover, the total numbers of piglets born and those born alive did not differ among the three groups. These findings suggested that 0.5&#x202f;mg KP-10 given at 96&#x202f;h after weaning could be used in FTAI programmes to manage batch farrowing in sows.

Study Information

Provider

pubmed

Year

2022

Date

2022-04-15T00:00:00.000Z

DOI

10.1016/j.animal.2022.100509

Citations

3

References

30